Anti-adhesion antibodies Efalizumab, a humanized anti-CD11a monoclonal antibody

Transplant Immunology

Volumn 9, Issue 2-4, 2002, Pages 181-186

  Dedrick, Russell L ^a   Walicke, Patricia ^b   Garovoy, Marvin ^a  

^a XOMA Corporation   (United States)

^b GENENTECH INC   (United States)

Author keywords

Antibody; CD11a; Efalizumab; Humanized

Indexed keywords

BETA2 INTEGRIN; CD18 ANTIGEN; CYCLOSPORIN A; EFALIZUMAB; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1 MONOCLONAL ANTIBODY; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; OKT 3; PLACEBO; RAPAMYCIN; RECOMBINANT ANTIBODY; RECOMBINANT MONOCLONAL ANTIBODY CD11A; UNCLASSIFIED DRUG; MONOCLONAL ANTIBODY;

ALLOGRAFT; ANTIGEN PRESENTING CELL; CELL INTERACTION; CLINICAL TRIAL; CONFERENCE PAPER; DENDRITIC CELL; DISEASE SEVERITY; DOSE RESPONSE; DRUG BINDING; DRUG EFFICACY; DRUG HALF LIFE; DRUG POTENTIATION; DRUG TARGETING; DRUG TOLERABILITY; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FLU LIKE SYNDROME; GRAFT REJECTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INFLAMMATION; KIDNEY TRANSPLANTATION; LEUKOCYTE ADHERENCE; LYMPHOCYTE DEPLETION; MOLECULE; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PSORIASIS; T LYMPHOCYTE; DRUG INTERACTION; IMMUNOLOGY; PHYSIOLOGY; REVIEW;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD11A; DRUG INTERACTIONS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; PSORIASIS;

EID: 0035746070     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0966-3274(02)00029-1     Document Type: Conference Paper

References (29)

1. Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
2. Lymphocyte homing and homeostasis
3. α4 integrins mediate lymphocyte attachment and rolling under physiologic flow
4. DC-SIGN-ICAM-2 interaction mediates dendritic cell trafficking
5. CD44 and its ligand hyaluronate mediate rolling under physiologic flow: A novel lymphocyte-endothelial cell primary adhesion pathway
6. + T cells migrate into inflamed skin only if they express ligands for E- and P-selectin
7. Chemokines, chemokine receptors and allograft rejection
8. Extracellular matrix proteins in organ transplantation
9. Potent costimulation of effector T lymphocytes by human collagen type I
10. Antigen presentation in extracellular matrix: Interactions of T cells with dendritic cells are dynamic, short lived and sequential
11. The immunological synapse: A molecular machine controlling T cell activation
12. Three-dimensional segregation of supramolecular activation clusters in T cells
13. Structure and function of the leukocyte adhesion molecules CD11/CD18
14. Mechanisms of monoclonal antibody-facilitated tolerance induction: A possible role for the CD4 (L3T4) and CD11a (LFA-1) molecules in self-non-self discrimination
15. Potent and effective prolongation by anti-LFA-1 monoclonal antibody monotherapy of non-primarily vascularized heart allograft survival in mice without T cell depletion
16. Prolonged inhibition of obliterative airway disease in murine tracheal allografts by brief treatment with anti-leukocyte function-associated antigen-1 (CD11a) monoclonal antibody
17. Humanization of an anti-lymphocyte function-associated antigen (LFA)-1 monoclonal antibody and reengineering of the humanized antibody for binding to rhesus LFA-1
18. Population pharmacokinetics and pharmacodynamics of the anti-CD11a antibody hu1124 in human subjects with psoriasis
19. Effects of administration of a single dose of a humanized monoclonal antibody to CD11a on the immunobiology and clinical activity of psoriasis
20. Psoriasis as a model for T-cell-mediated disease: Immunologic and clinical effects of treatment with multiple doses of an anti-CD11a antibody
21. The effective treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibody
22. Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune, but not keratinocyte, pathogenic basis
23. The pathogenesis of psoriasis: Immunological facts and speculations
24. Severe psoriasis-oral therapy with a new retinoid
25. Administration of ant anti-CD11a monoclonal antibody in recipients of kidney transplantation: A pilot study
26. Effect of anti-LFA-1 (CD11a) monoclonal antibodies in acute rejection in human kidney transplantation
27. Anti-LFA-1 monoclonal antibody (25.3) for treatment of steroid-resistant grade III-IV acute graft-versus-host disease
28. Synergistic effects of mycophenolate mofetil (MMF, RS-61 443) and anti-LFA-1/ICAM-1 monoclonal antibodies on the prolongation of heart allograft survival in rats
29. Release of tumor necrosis factor, interleukin-2 and gamma-inerferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients